Clinical study for the treatment of atherosclerotic angiopathy with traditional Chinese Medicine
Phase 1
Recruiting
- Conditions
- atherosclerosis
- Registration Number
- ITMCTR1900002732
- Lead Sponsor
- Hebei Petro China Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. CTA showing lower extremity vascular stenosis,Stenosis > 40%;
2. Aged 30 to 70 years, regardless of gender;
3. Those who can adhere to long-term medication;
4. Patients who volunteer to participate in the study, informed consent, and signed informed consent.
Exclusion Criteria
1. There are serious diseases such as heart, liver, kidney, hematopoietic system, endocrine system, respiratory system, etc.,
2. Pregnant or lactating women;
3. Allergic constitution;
4. Other diseases or psychosis that the investigator believes may limit efficacy evaluation or patient follow-up;
5. Patients who have participated in other drug clinical trials in the past 4 weeks.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CT angiography;
- Secondary Outcome Measures
Name Time Method Color Doppler ultrasound;